Hoxton Planning & Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $235K | Sell |
3,402
-294
| -8% | -$20.3K | 0.08% | 180 |
|
|
2025
Q1 | $257K | Sell |
3,696
-3
| -0.1% | -$208 | 0.1% | 165 |
|
|
2024
Q4 | $318K | Buy |
3,699
+21
| +0.6% | +$1.81K | 0.12% | 147 |
|
|
2024
Q3 | $438K | Buy |
3,678
+80
| +2% | +$9.53K | 0.17% | 109 |
|
|
2024
Q2 | $514K | Sell |
3,598
-14
| -0.4% | -$2K | 0.24% | 81 |
|
|
2024
Q1 | $464K | Sell |
3,612
-20
| -0.6% | -$2.57K | 0.22% | 89 |
|
|
2023
Q4 | $376K | Buy |
3,632
+171
| +5% | +$17.7K | 0.2% | 90 |
|
|
2023
Q3 | $315K | Buy |
3,461
+145
| +4% | +$13.2K | 0.2% | 97 |
|
|
2023
Q2 | $268K | Buy |
3,316
+442
| +15% | +$35.8K | 0.17% | 113 |
|
|
2023
Q1 | $229K | Buy |
+2,874
| New | +$229K | 0.13% | 140 |
|